Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: A conversation between aging researchers and FDA regulators

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 64, Issue 4, 2009, Pages 487-491

  Bhasin, Shalender ^a   Espeland, Mark A ^b   Evans, William J ^c   Ferrucci, Luigi ^d   Fried, Linda P ^e   Gill, Thomas M ^f   Pahor, Marco ^g   Studenski, Stephanie ^h   Guralnik, Jack ⁱ   Nayfield, Susan ^j   Romashkin, Sergei ^j   Perlstein, Robert ^k   Burke, Laurie ^k   Parks, Mary ^k  

^a University School of Medicine

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e Department of Obstetrics Gynecology   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ NIA (Laboratory of Epidemiology Demography and Biometry)   (United States)

^j NIA Geriatrics and Clinical Gerontology Program

^k CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CLINICAL EVALUATION; CLINICAL PRACTICE; DRUG USE; FOOD AND DRUG ADMINISTRATION; FRAIL ELDERLY; HEALTH PROGRAM; HEALTH STATUS; HUMAN; MUSCLE ATROPHY; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; VITAMIN SUPPLEMENTATION; WALKING DIFFICULTY; AGED; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FITNESS; GERIATRIC ASSESSMENT; INTERDISCIPLINARY COMMUNICATION; MALE; PHYSIOLOGY; RESEARCH; SENSITIVITY AND SPECIFICITY; STANDARD; UNITED STATES;

DRUG;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; AGING; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRAIL ELDERLY; GERIATRIC ASSESSMENT; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACEUTICAL PREPARATIONS; PHYSICAL FITNESS; PRACTICE GUIDELINES AS TOPIC; RESEARCH; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 64849099557     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/gln042     Document Type: Review

References (31)

1. Working Group on Functional Outcome Measures for Clinical Trials. Functional outcomes for clinical trials in frail older persons. Time to be moving. J Gerontol Med Sci. 2008;63A:160-165.
2. Morley JE. Anorexia and weight loss in older persons. J Gerontol A Biol Sci Med Sci. 2003;58:131-137.
3. Thomas DR, Verdery RB, Gardner L, Kant A, Lindsay J. A prospective study of outcome from protein-energy malnutrition in nursing home residents. Jpen J Parenter Enteral Nutr. 1991;15:400-404.
4. Thomas DR, Ashmen W, Morley JE, Evans WJ. Nutritional management in long-term care: development of a clinical guideline. J Gerontol Med Sci. 2000;55A:M725-M734. (Pubitemid 32175755)
5. Morley JE. Orexigenic and anabolic agents. Clin Geriatr Med. 2002;18:853-866.
6. Evans WJ. Editorial: megestrol acetate use for weight gain should be carefully considered. [comment]. J Clin Endocrinol Metab. 2007;92:420-421.
7. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-M156. (Pubitemid 32187141)
8. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59:255-263. (Pubitemid 38375339)
9. Walston J. Frailty-the search for underlying causes. Sci Aging Knowledge Environ. 2004;2004:pe4.
10. Cesari M, Leeuwenburgh C, Lauretani F, et al. Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study. Am J Clin Nutr. 2006;83:1142-1148. (Pubitemid 44713116)
11. Bartali B, Frongillo EA, Bandinelli S, et al. Low nutrient intake is an essential component of frailty in older persons. J Gerontol A Biol Sci Med Sci. 2006;61:589-593. (Pubitemid 43912097)
12. Leng S, Chaves P, Koenig K, Walston J. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc. 2002;50:1268-1271. (Pubitemid 34774552)
13. Montero-Odasso M, Duque G. Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol Aspects Med. 2005;26:203-219. (Pubitemid 40462027)
14. Morley JE, Kim MJ, Haren MT. Frailty and hormones. Rev Endocr Metab Disord. 2005;6:101-108.
15. Evans W. What is sarcopenia? J Gerontol. 1995; 50A(special issue):5-8.
16. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50:889-896. (Pubitemid 34496687)
17. Walsh MC, Hunter GR, Livingstone MB. Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density. Osteoporos Int. 2006;17:61-67. (Pubitemid 41798029)
18. Ferrucci L, Russo CR, Lauretani F, Bandinelli S, Guralnik JM. A role for sarcopenia in late-life osteoporosis. Aging Clin Exp Res. 2002;14:1-4.
19. Lebrun CE, van der Schouw YT, de Jong FH, Grobbee DE, Lamberts SW. Fat mass rather than muscle strength is the major determinant of physical function and disability in postmenopausal women younger than 75 years of age. Menopause. 2006;13:474-481.
20. Newman AB, Kupelian V, Visser M, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci. 2006;61:72-77. (Pubitemid 43227803)
21. Sowers MR, Crutchfield M, Richards K, et al. Sarcopenia is related to physical functioning and leg strength in middle-aged women. J Gerontol A Biol Sci Med Sci. 2005;60:486-490. (Pubitemid 40712867)
22. Campbell WW, Trappe TA, Wolfe RR, Evans WJ. The recommended dietary allowance for protein may not be adequate for older people to maintain skeletal muscle. J Gerontol A Biol Sci Med Sci. 2001;56:M373-M380.
23. Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003;88:5766-5772. (Pubitemid 38033048)
24. Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Singh MA. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr. 2002;76:473-481. (Pubitemid 34804075)
25. Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med. 2006;119:526 e9-e17. (Pubitemid 43795180)
26. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755-763. [Published erratum appears in Am J Epidermiol. 1999 Jun 15:149(12):1161]. (Pubitemid 28183275)
27. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002;57:M772-M777. (Pubitemid 35470952)
28. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52:80-85. (Pubitemid 38090394)
29. Bhasin S, Woodhouse L, Casaburi R, et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab. 2005;90:678-688. (Pubitemid 40279179)
30. Frontera WR, Meredith CN, O'Reilly KP, Knuttgen HG, Evans WJ. Strength conditioning in older men: skeletal muscle hypertrophy and improved function. J Appl Physiol. 1988;64:1038-1044.
31. Fiatarone MA, O'Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med. 1994;330:1769-1775. (Pubitemid 24177611)